MCI-225, a novel thienopyrimidine analog, enhances attentional eye tracking in midpontine pretrigeminal preparation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1997-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0091-3057(96)00228-6PMID 9050079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of MCI-225 on memory and glucose utilization in basal forebrain-lesioned rats.

  1995cited by this paper
• Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

  1994cited by this paper
• Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

  1993cited by this paper
• The effect of ondansetron on cognitive performance in the marmoset.

  1991cited by this paper
• Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders.

  1991cited by this paper
• Impaired eye tracking performance in patients with presenile onset dementia.

  1991cited by this paper
• The effects of background illumination and stimulant medication on smooth pursuit eye movements of hyperactive children

  1989cited by this paper
• 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

  1989cited by this paper
• Cognitive models and cholinergic drugs.

  1989cited by this paper
• Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes.

  1989cited by this paper
• The role of cognition in child development and disorder.

  1987cited by this paper
• Regulation of α and β components of noradrenergic cyclic AMP response in cortical slices

  1987cited by this paper
• Regulation of alpha and beta components of noradrenergic cyclic AMP response in cortical slices.

  1987cited by this paper
• Catecholamines and attention. II: Pharmacological studies in normal humans.

  1987cited by this paper
• Catecholamines and attention. I: Animal and clinical studies.

  1987cited by this paper
• Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.

  1986cited by this paper
• Functional decline in the early stages of Alzheimer's disease.

  1986cited by this paper
• The Pharmacodynamic Properties of Lorazepam and Methylphenidate Drugs on Event-Related Potentials and Power Spectral Analysis in Normal Subjects

  1986cited by this paper
• Effects of dopaminergic agents on eye tracking before and after repeated methamphetamine.

  1986cited by this paper
• Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.

  1984cited by this paper
• Desipramine in the treatment of adolescents with attention deficit disorder.

  1984cited by this paper
• Desipramine: an overview.

  1984cited by this paper
• Eye tracking dysfunction in Alzheimer‐type dementia

  1984cited by this paper
• Cognitive functioning in depression: a review of theory and research

  1984cited by this paper
• Memory, attention, and functional status in community-residing Alzheimer type dementia patients and optimally healthy aged individuals.

  1984cited by this paper
• Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.

  1984cited by this paper
• Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.

  1983cited by this paper
• Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

  1981cited by this paper
• Inhibition of intracranial self-stimulation in brain stem-transected cats--a proposed mechanism of aversive effects produced by brain stimulation.

  1981cited by this paper
• Noradrenaline and selective attention: a review of the model and the evidence.

  1980cited by this paper
• Performance on three cognitive tasks by patients with dementia, depression or Korsakov's syndrome.

  1979cited by this paper
• The locus coeruleus: neurobiology of a central noradrenergic nucleus.

  1977cited by this paper
• Effects of selective forebrain noradrenaline loss on behavioral inhibition in the rat.

  1977cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Hyperkinetic children: the use of stimulant drugs evaluated.

  1975cited by this paper
• Interaction of imipramine and desmethylimipramine with tremorine and oxotremorine in mice.

  1967cited by this paper
• The effect of imipramine, desmethylimipramine and chlorpromazine on the sleep-wakefulness cycle of the cat.

  1965cited by this paper
• EFFECTS OF CENTRALLY ACTING DRUGS ON THE CORRELATION OF ELECTROCORTICAL ACTIVITY AND WAKEFULNESS OF CATS

  1962cited by this paper
• Effects of centrally acting drugs on the correlation of electrocortical activity and wakeful of cats.

  1962cited by this paper
• Effects of complete pontine transections on the sleep-wakefulness rhythm: the midpontine pretrigeminal preparation

  1959cited by this paper

• Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.

  2023cites this paper
• Effects of Stimulus Predictability and Interstimulus Gap on Saccades in Alzheimer’s Disease

  2002cites this paper
• The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism.

  2001cites this paper
• Effects of acute and chronic administration of MCI-225, a new selective noradrenaline reuptake inhibitor with 5-HT3 receptor blocking action, on extracellular noradrenaline levels in the hypothalamus of stressed rats.

  2000cites this paper